Literature DB >> 18780536

Temporomandibular joint pressure pain threshold is systemically modulated in rheumatoid arthritis.

Per Alstergren1, Lars Fredriksson, Sigvard Kopp.   

Abstract

AIMS: To investigate the relative importance of systemic and local inflammatory mediators (serotonin: 5-HT; tumor necrosis factor: TNF; soluble interleukin-1 receptor II: IL-1sRII) in the modulation of temporomandibular joint (TMJ) pressure pain threshold in patients with seropositive or seronegative rheumatoid arthritis (RA) and to investigate to what extent TMJ pressure pain threshold is related to other TMJ pain parameters.
METHODS: Sixty patients with seropositive RA for rheumatoid factor and 74 patients with seronegative RA involving the TMJ were investigated regarding synovial fluid and plasma levels of IL-1sRII, 5-HT, and TNF as well as erythrocyte sedimentation rate, C-reactive protein, thrombocyte particle count, and rheumatoid factor in blood. TMJ resting pain, movement pain, tenderness, and palpebral pain reflex to digital palpation and TMJ pressure pain threshold were examined.
RESULTS: Statistical analyses indicated that TMJ pressure pain threshold was only correlated to systemic factors. TMJ movement pain was in turn mainly correlated to systemic mediators in the seropositive patients but to local mediators in the seronegative patients where synovial fluid IL-1sRII was positively correlated to TMJ pain on mouth opening. Seropositive patients had higher systemic inflammatory activity but lower TMJ movement pain intensities than seronegative patients.
CONCLUSION: The results indicate that TMJ pressure pain threshold is modulated by systemic rather than local inflammatory mediators and suggest that it is unrelated or only weakly related to other TMJ pain entities in RA patients. A rheumatoid factor-dependent systemic modulation, in combination with local factors, seems to account for TMJ pain in RA patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18780536

Source DB:  PubMed          Journal:  J Orofac Pain        ISSN: 1064-6655


  6 in total

Review 1.  Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders.

Authors:  C C Peck; J-P Goulet; F Lobbezoo; E L Schiffman; P Alstergren; G C Anderson; R de Leeuw; R Jensen; A Michelotti; R Ohrbach; A Petersson; T List
Journal:  J Oral Rehabil       Date:  2014-01       Impact factor: 3.837

2.  Temporomandibular disorders in patients with early rheumatoid arthritis and at-risk individuals in the Dutch population: a cross-sectional study.

Authors:  Johanna M Kroese; Catherine M C Volgenant; Wim Crielaard; Bruno Loos; Dirkjan van Schaardenburg; Corine M Visscher; Frank Lobbezoo
Journal:  RMD Open       Date:  2021-01

3.  Prevalence and Severity of Temporomandibular Disorders in Rheumatoid Arthritis Patients.

Authors:  Mohammad A Mustafa; Bader A Al-Attas; Fatma F Badr; Fatma M Jadu; Siraj O Wali; Yasser M Bawazir
Journal:  Cureus       Date:  2022-01-15

4.  The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study.

Authors:  Yvonne C Lee; Lori B Chibnik; Bing Lu; Ajay D Wasan; Robert R Edwards; Anne H Fossel; Simon M Helfgott; Daniel H Solomon; Daniel J Clauw; Elizabeth W Karlson
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

5.  Impact of temporomandibular joint pain in rheumatoid arthritis.

Authors:  Neveen Ahmed; Hamid Masoud Mustafa; Anca Irinel Catrina; Per Alstergren
Journal:  Mediators Inflamm       Date:  2013-12-09       Impact factor: 4.711

6.  Corticosteroid injections in the temporomandibular joint temporarily alleviate pain and improve function in rheumatoid arthritis.

Authors:  Johanna Margaretha Kroese; Sigvard Kopp; Frank Lobbezoo; Per Alstergren
Journal:  Clin Rheumatol       Date:  2021-07-21       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.